Explore
Validate
LearnABIN1106926
antibody from antibodies-online
Targeting: KRT23
CK23, DKFZP434G032, HAIK1, K23, MGC26158
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1106926 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Keratin 23 (KRT23) (AA 271-422) antibody
- Antibody type
- Monoclonal
- Description
- Protein-G affinity chromatography
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 271-422
- Isotype
- IgG
- Antibody clone number
- AT2F6
- Vial size
- 50 μL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro.
The human type I keratin gene family: characterization of new hair follicle specific members and evaluation of the chromosome 17q21.2 gene domain.
Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
Birkenkamp-Demtroder K, Mansilla F, Sørensen FB, Kruhøffer M, Cabezón T, Christensen LL, Aaltonen LA, Verspaget HW, Ørntoft TF
Molecular oncology 2007 Sep;1(2):181-95
Molecular oncology 2007 Sep;1(2):181-95
The human type I keratin gene family: characterization of new hair follicle specific members and evaluation of the chromosome 17q21.2 gene domain.
Rogers MA, Winter H, Langbein L, Bleiler R, Schweizer J
Differentiation; research in biological diversity 2004 Dec;72(9-10):527-40
Differentiation; research in biological diversity 2004 Dec;72(9-10):527-40
Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
Zhang JS, Wang L, Huang H, Nelson M, Smith DI
Genes, chromosomes & cancer 2001 Feb;30(2):123-35
Genes, chromosomes & cancer 2001 Feb;30(2):123-35
No comments: Submit comment
No validations: Submit validation data